Golden State Equity Partners’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-90
Closed -$1.68K 1195
2026
Q1
$1.68K Buy
+90
New +$1.7K ﹤0.01% 1703

Other funds holding MRNY

Golden State Equity Partners's MRNY Position: Q2 2026 in Review

Golden State Equity Partners sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026, closing a stake of 90 shares — an estimated $1.68K sold.

Golden State Equity Partners first reported a position in MRNY in Q1 2026 and held it in 1 quarter. The position peaked at $1.68K in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Golden State Equity Partners reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 90 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $1.68K.
  • Golden State Equity Partners first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2026 and held it in 1 quarter.
  • Golden State Equity Partners's YieldMax MRNA Option Income Strategy ETF position peaked at $1.68K in Q1 2026.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.